Soon-oh Hong

Seoul, Republic of Korea

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

KLS-3021, a multifunctional oncolytic virus, demonstrates potent early-intervention efficacy in preclinical models of prostate-confined and locally advanced prostate cancer.

KLS-3021, a multifunctional oncolytic virus, demonstrates potent early-intervention efficacy in preclinical models of prostate-confined and locally advanced prostate cancer.

Journal: Frontiers in oncology

Published: December 11, 2025

KLS-3021: Innovative oncolytic virotherapy for the treatment of advanced primary and metastatic cutaneous squamous cell carcinoma.

KLS-3021: Innovative oncolytic virotherapy for the treatment of advanced primary and metastatic cutaneous squamous cell carcinoma.

Journal: Molecular therapy. Oncology

Published: November 10, 2025

Transgenic viral expression of PH-20, IL-12, and sPD1-Fc enhances immune cell infiltration and anti-tumor efficacy of an oncolytic virus.

Transgenic viral expression of PH-20, IL-12, and sPD1-Fc enhances immune cell infiltration and anti-tumor efficacy of an oncolytic virus.

Journal: Molecular therapy oncolytics

Published: March 22, 2023

Generation of a Novel Oncolytic Vaccinia Virus Using the IHD-W Strain.

Generation of a Novel Oncolytic Vaccinia Virus Using the IHD-W Strain.

Journal: Human gene therapy

Published: August 29, 2020

LC3B upregulation by NANOG promotes immune resistance and stem-like property through hyperactivation of EGFR signaling in immune-refractory tumor cells.

LC3B upregulation by NANOG promotes immune resistance and stem-like property through hyperactivation of EGFR signaling in immune-refractory tumor cells.

Journal: Autophagy

Published: August 09, 2020

HDAC1 Upregulation by NANOG Promotes Multidrug Resistance and a Stem-like Phenotype in Immune Edited Tumor Cells.

HDAC1 Upregulation by NANOG Promotes Multidrug Resistance and a Stem-like Phenotype in Immune Edited Tumor Cells.

Journal: Cancer research

Published: January 13, 2017

API5 induces cisplatin resistance through FGFR signaling in human cancer cells.

API5 induces cisplatin resistance through FGFR signaling in human cancer cells.

Journal: Experimental & molecular medicine

Published: December 26, 2016

Ulmus davidiana Nakai induces apoptosis and autophagy on non-small cell lung cancer cells.

Ulmus davidiana Nakai induces apoptosis and autophagy on non-small cell lung cancer cells.

Journal: Journal of ethnopharmacology

Published: December 14, 2016

REP1 inhibits FOXO3-mediated apoptosis to promote cancer cell survival.

REP1 inhibits FOXO3-mediated apoptosis to promote cancer cell survival.

Journal: Cell death & disease

Published: October 18, 2016

Targeting stemness is an effective strategy to control EML4-ALK+ non-small cell lung cancer cells.

Targeting stemness is an effective strategy to control EML4-ALK+ non-small cell lung cancer cells.

Journal: Oncotarget

Published: July 13, 2015

Showing 1-10 of 10

Last Updated: 09/26/2026